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Abstract 
We study the interactions between normal and abnormal cell populations as they 
occur in a tumorous growth. The purpose of our research is determine whether the 
spatial arrangement of abnormal cells in a tissue is a significant factor governing the 
spread of the tumor. To this end, we model how normal and abnormal cells compete for 
nutrients using a deterministic model and a spatial stochastic model. We vary nutrient 
competition rates as well as drug treatment effects for the two cell populations. The 
deterministic model indicates how the populations interact without consideration of 
spatial arrangement, while the stochastic model includes this factor. Our results show 
that different spatial arrangements of cells may cause significant differences in the growth 
dynamics of the cells even if the initial population sizes are kept constant. We have 
found that the spatial model reveals some growth dynamics that the deterministic model 
overlooks. Therefore it is of interest to obtain more realistic spatial models. For this, we 
; , need to focus research on the most distinctive factor of the spatial model: how normal 
and malignant cells on the boundary of a tumor compete for nutrients. 
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1 Introduction 
Cancer is a seemingly unpredictable illness that is prevalent among adults and children around 
the world. In fact, one out of every five persons will die as a result of cancer. Cancer 
begins when normal cells genetically mutate into abnormal cells, which have the mutant gene, 
oncogene (Alberts 1994). These abnormal cells grow exponentially and take nutrients from 
their cellular surrounding, which causes nearby normal cells to die. 
The mutation of normal cells into abnormal cells can result from many factors, including 
exposure to the sun, chemical products, water, food, air, etc. However, even "in an environ-
ment that is free of mutagens, mutations will occur spontaneously at an estimated rate of 
about w-6 mutations per gene per cell division- a value set by the fundamental limitations 
on the accuracy of DNA replication and repair. (Alberts 1994). 
The mutation from a normal cell to an abnormal cell is quite unpredictable. From statisti-
cal data, it is estimated that somewhere between three and seven consecutive random events 
of mutations, each of low probability, are typically required to turn normal cells into abnormal 
cells (Alberts 1994). 
After normal cells have mutated into abnormal cells, a tumor may begin to grow, and 
it ewntually starts to vascularize. This enables abnormal cells in the center of a tumor to 
receiw nutrients that would otherwise be available only to the abnormal cells on the surface 
of the tumor. Vascularization, thus, works as a system of irrigation, which allows the growth 
of abnormal cells to occur more rapidly than that of normal cells. 
:\Ioreover, as a tumor grows, abnormal and normal cells begin to compete for nutrients. 
Abnormal cells win this competition. They receive more nutrients than normal cells because 
the:· gTow at a faster rate than normal cells and eventually take up a greater volume than 
normal cells in their respective, cellular surroundings. This results in a lack of nutrients to 
normal cells, which causes many of them to eventually die. 
Another characteristic of abnormal cell populations that explains their tendency to outgrow 
normal cell populations is their lack of "contact inhibition." Contact inhibition occurs when 
normal cell growth ceases due to the spatial accumulation of cells. After a certain density 
of normal cells is reached, normal cells cease to reproduce. Hence, normal cell growth has 
a threshold limited to the amount of available space in a specific amount of cellular tissue. 
Abnormal cells, in contrasts, do not have this threshold; they grow and affect other cells 
\\ithout regard to contact inhibition. 
In this paper, we analyze how the two types of cells interact using a deterministic model 
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and a spatial stochastic model. Comparing the results from the two models allows us to see 
whether the spatial arrangement of abnormal cells plays a significant role in the development 
of a tumor. Throughout our paper we describe both the deterministic and stochastic spatial 
models. We also describe how we determine the parameters. Finally, we present our results 
and suggestions for further research. 
2 Methodology 
In our project, we develop a deterministic model and a spatial stochastic inodel to simulate how 
normal and abnormal cells in organic tissue interact. The deterministic model shows us how 
normal and abnormal cells compete with each other without taking into account the spatial 
arrangement of cells. The stochastic model in contrast, does take this factor into account. 
Thus, by comparing the two models, we can determine whether the spatial arrangement of 
cells is a significant factor in studying tumor growth. 
In the following sections, we will explain how we establish our two models, the parameters 
we chose, and how we analyze the two models. 
2.1 The Deterministic Model 
Our deterministic model is as follows: 
dN 
dt 
dA 
dt 
Interpretation of symbols: 
N is the number of normal cells; 
A is the number of abnormal cells; 
k0 is a constant; 
k1 is a constant; 
-\0 is the birth rate of normal cells; 
(1) 
(2) 
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..\1 is the birth rate ofabnormal cells; 
80 is the death rate of normal cells due to natural death; 
81 is the death rate of abnormal cells due to natural death; 
d0 is the death rate of normal cells due to drug treatment; 
d1 is the death rate of abnormal cells due to drug treatment; 
p is the proportion of abnormal cells that take nutrients from normal cells; 
ko(Ao - 8o -do) 
Ao 
is the carrying capacity of the normal cells; 
is the carrying capacity of the abnormal cells; 
and 
AN 
mN+b 
is the number of normal cells that die due "intervascularization". 
The carrying capacity for abnormal growth is considered finite because of a phenomena 
that occurs in neoplasms (or hard tumors). The constants are determined and discussed in 
the parameter section. When a tumor grows, it vascularizes so that abnormal cells in the 
center of the growth access nutrients that would otherwise be available only to the abnormal 
cells on the surface. This system supports abnormal cells in the center of the tumor while the 
ratio of volume to surface area of the growth is sufficiently large. Otherwise, the system is too 
inefficient, and the abnormal cells inside the tumor lose in the competition for nutrients and 
die (Yen 1997). This self-competition for nutrients explains why we modeled the abnormal 
growth with a carrying capacity. We must mention that the competition for nutrients between 
normal and abnormal cells does not significantly contribute to abnormal cell death (Velasco 
1997). Finally, the rate at which normal cells mutate into abnormal cells is so small, that it 
is negligible for our purposes (Yen 1997). 
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2.2 Determining the Parameter Values 
The competition factor, AN/(mN +b), tells us the rate of change of normal cells due to 
competition for nutrients. In Figure 1 we see that when either the populations is low then 
the competition factor is small. Also when the population of abnormal cells is large then the 
competition factor is large. 
We want the per capita competition factor to reflect some realistic situations. For example, 
when there is a small number of normal cells then we expect the competition factor to be its 
greatest. And when the number of normal cells is large then \Ve expect the competition factor 
to be small. 
If we assume that b = 350 and m = 240 then 
A A 
------ - ---------
mN+b 240N+350 
is the per capita rate of change of normal cells due to competition of nutrients. 
Practically we have control over only the drugs that can be administered to a patient. 
Consequently, we can control only the variables d0 and d1 . We researched the other rates and 
found the birth and death rates of normal and abnormal cells to be: 
>.o = 7.2% (Fry 1969); 
8o = 5.3%; 
>. 1 = 18% (Fry 1969); and 
81 = 12% (Baserga 1985); 
where we have approximated 80 . 
Another significant factor, drug rates, is also considered. For example, the drug Vincristine, 
has been found to kill abnormal cells at a rate of 4% (Baserga 1982). It has been shown that 
normal cells are more resistant to certain drugs than abnormal cells. Swan asserts, for example, 
that "the normal cell population is expected to recover at a much faster rate than the tumor 
cell population" (Swan 1982). 
We know that for our two models to produce results on the same scale we need 
0 < ko < 4910 
and 
0 < k1 < 16920. 
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2.3 The Stochastic Model 
For the stochastic model, we set up a 25 x 25 patch grid. Each patch on the grid has four 
possible states: E (empty), N (normal cell), A (abnormal cell), or D (dead cell). During the 
simulation, four basic events can occur: (1) E--+ N (a normal cell is born); (2) E--+ A (an 
abnormal cell is born); (3) N --+ E or N --+ D (a normal cell dies); and A --+ E or A --+ D 
(an abnormal cell dies). Selecting the next event on the grid is a four-step process described 
below. 
Step 1: Setting up the weights of each event 
To each patch of the grid corresponds a four-component vector containing the weights, of 
the four basic events. These weights are assigned to each patch with an algorithm that respects 
the dynamical properties of the deterministic model, while incorporating spatial factors that 
the deterministic model cannot account for. Specifically, the weight of each event for each 
patch (referring to the patch as P) is calculated as follows: 
Weight(£--+ N) = ~0 (#of N cells in the 8-patch neighborhood of P) 
if state of P =E. 
- 0 otherwise. 
Weight(E--+ A) i (#of A cells in the 8-patch neighborhood of P) 
Weight(N--+ E or N--+ D) (80 + d0 +Po) (#of A cells in the 8-patch neighborhood 
of P) if state of P = N. 
Weight(A--+ E or A--+ D) 
0 otherwise. 
81 + d1 if state of P =A and # of A cells in the 8-pat.ch 
neighborhood of P < 8 
81 + d1 +Po ( # of A cells in the 24-patch neighborhood 
of P) if state of P = A and # of A cells in the 8-patch 
neighborhood= 8. 
0 otherwise. 
where p0 is the death rate due to competition for nutrients with abnormal cells. 
For example, a section of the grid could look like this: 
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E A A E E N 
N E A A N E 
E E N E N N 
N E N N E E 
E N E N E N 
E E E N N N 
In this case, the weights at the patch containing the bold E would be as follows: 
Weight(E--+ N) 5Ao 
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Weight(E--+ A) 2A1 
8 
Weight(N--+ E) 0 
Weight(A--+ E) - 0. 
Events E--+ Nand E--+ A would be possible on this patch, while the other two would not. 
Step 2: Choosing the time for the next event 
Here, we use an exponential function with parameter 1 = total event rate. We calculate 
1 by adding the weights of each event for all the patches in the grid. 
Step 3: Choosing the next event 
We first add the total weights for each event on the whole grid and place the sums into a 
4-element vector. From this weighted vector, we randomly select one of the four events. 
Step 4: Choosing a patch for the event 
We produce a 625-element vector containing the weight at each patch of the chosen event. 
From this weighted vector, we randomly select an element, which will correspond to one of 
the patches on the grid. 
Special Cases: There are two special cases to consider. First, when the event E--+ A is chosen 
on a non-empty patch, "shifting" occurs. For example, if the A below is to reproduce into the 
space to the left of it, the new A would shift the two other cells one space to the left, until 
either an empty space is filled, or the edge of the grid is reached. 
Second, we incorporate a state D to represent the dead cells in the middle of an abnormal 
core. The idea behind this is that in real tumor tissue, dead cells in the center of the tumor 
cannot escape the system. We modeled this as follows. If either an N or A cell dies, and its 
8-patch neighborhood is entirely A cells, then it will become a D cell. If at any point, there is 
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an E patch in the 8-patch neighborhood of aD cell, the D cell will become E. This is simply 
an updating action and does-not count as an event in the stochastic process. 
Initial Conditions We begin each simulation with certain arrangements of N and A cells 
throughout the grid. In most cases, we vary only the spatial arrangement of cells, and not 
the number of cells of each type. For instance, we keep the N and A count at 156 and 15, 
respectively, but in one initial condition, we arrange the A cells in one lump, while in the 
other, we disperse them evenly throughout the grid. In general, we run the simulations until 
a steady state is reached ( 1000 frames). 
3 Results 
3.1 Deterministic Model 
After finding reasonable parameter values for our differential equations, we calculated the 
equilibrium points. We found three equilibria: 
Eo (0, 0), 
E1 ( ko(.\o -,\:o -do), 0) 
E2 _ ( O, k1 (.\1 -.\:1 - di)) 
Since these are equilibria, if the populations are any of these, the system will not change 
in time. 
Next we found stability at each of these equilibria by linearizing both of our equation::; 
and obtaining Jacobian matrices for each equilibria. This allows us to analyze local stability 
around each equilibrium point by evaluating the trace and the determinant of each Jacobian 
matrix. 
Using the determined parameters, we found equilibria in terms of d0 and d1. We carried 
out the stability analysis also in terms of do and d1. This allowed us to find conditions on do 
and d1 under which we could eradicate the cancer and save normal cells. So we want Noo > 0 
and Aoo = 0 to be stable. 
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3.2 Stochastic Results 
Due to time constraints, we have not run sufficiently many simulations to obtain quantitative 
results from the stochastic model. However, we have obtained preliminary qualitative results. 
We have adjusted the death rate due to drugs of abnormal cells so that the total death rate of 
abnormal cells is similar to the total birth rate of abnormal cells. Using these rates, we have 
set up two initial conditions (Figure 2 and Figure 3) that differ only in the spatial arrangement 
of abnormal cells. 
In both grids, there are 156 normal cells and 15 abnormal cells. In Figure 2, the abnormal 
cells are all lumped together in the middle of the grid, while Figure 3 has the abnormal cells 
dispersed evenly. Running simulations from these initial conditions shows that the lumped 
cells are more likely to survive. While simulations from Figure 3 results in rapid extinction 
of abnormal cells (Figure 5), the abnormal cells survive and in fact grow to eventually kill off 
the normal cells (Figure 4). 
This result tells us something interesting about the cellular dynamics of our model. If 
our model is realistic, this might also suggest a treatment strategy that includes attacking 
abnormal cells in their weaker state, when they are dispersed. This result could not have been 
predicted by the non-spatial deterministic model. 
4 Discussion 
Results from the deterministic model produce a range of values for d0 and d1, such that the 
abnormal cell population can be eliminated while preserving the normal cell population. The 
stochastic results, on the other hand, show that these values of dO and d1 are variable, and 
depend strongly on the spatial arrangement of abnormal cells. The dynamics of abnormal cell 
growth change considerably when these cells are lumped together compared to when they are 
dispersed. This fact suggests that a spatial stochastic model is able to produce a more complete 
picture of normal andabnormal cellular growth dynamics than a non-spatial deterministic one. 
It is therefore of interest to develop more realistic spatial models. To accomplish this, more 
needs to be known about the spatial factors in the dynamics of normal and abnormal. cell 
interaction. For example, we need a better estimate of the effect of nutrient competition on 
the boundary of a tumor, and the extent to which contact inhibition hinders the growth of 
normal cell populations. We suggest that further research be done in these areas. 
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Figure 1: Competition Factor. 
'!flt,'t!'t'I{JB_ ~ ~ r~ lri ff<• ~m ~ :o.;? 1(.-;,,:?% 
~ ~ ~ ~ ~~ r:nt·\ .. -._ ;1* t~ ~f..:t :~~~ ->Fi 
~ ~ ~ ~ ~~ 'r.:A t~ l'"~ i.."'1~ '-~, ~t 
- !'Ill --~ __ .,_l!t-:"'' "'~ lilll 1m fi§i 'ill' ~~ ;;p, ··~ ,, tf 
10 l!ii- J!li!l ~ lli1i f~'' M!'f, . . ~ ~ \::: l?'ii 
~ 1m '"f.il flll'·',,,, "" ~., ,_,.. <·:-- it 
15 ~ ill! IAI r;~"·.;: "-; ~ 
m m; • ~ 'lf~ ~~~·;;(.-~ ~~t if~ :-_: ... ~ :·~.: :.:i 
~ ~ ~-~~-'_-~ -?~1~ ~~ t't~ ~ ~-,..;: ·;:). ;~i;i 
... , -~-~ffi~: :_·.---~---._ 20 ~ ~~ ~ ~ .:,';;:~ f;.':,'~ :~~.-1 »$ . . <: ~~-
~~ ~ ~ ~~ }:4~ -~t.:¥ ~ ;, ·' ~~:~ 
®'iNit$ """ lM :·r,.: ,,,~ :w 'J?: .,_,_''·~~ 
··~--~~----=,.----~ .. ~--~.~.-----.~. 
Figure 2: Abnormal cells lumped together in the middle of the grid. 
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Figure 3: Abnormal cells dispersed evenly. 
12 
1~~--~--~--~--~--~--~--~--. 
~.;""" 
....... ---·.\, 
·., .. _./.~ .. ,-.,_." 140 
120 
100 
80 
0o~--5~~1~0--~1~5--~2~0--~2~5--~30~~35~~40' 
Figure 4: Normal and abnormal cells. Normal cells are extinct. 
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Figure 5: Normal and abnormal cells. Abnormal cells are extinct. 
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